Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant <i>Helicobacter pylori</i>

Development of Gastroretentive Floating Combination Tablets Containing Amoxicillin Trihydrate 500 mg and Levofloxacin 125 mg for Eradicating Resistant <i>Helicobacter pylori</i>

<b>Background/Objectives:</b> The aim of this work was to prepare and characterize gastroretentive floating combination tablets (GRCTs) containing 500 mg of amoxicillin trihydrate (AMX) and 125 mg of levofloxacin (LVX) that provide sustained drug release and stability at gastric pH level...

Full description

Bibliographic Details
Main Authors: Da Hun Kim, Sa-Won Lee, Jun Hak Lee, Jin Woo Park, Sung Mo Park, Han-Joo Maeng, Tae-Sung Koo, Kwan Hyung Cho
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Pharmaceutics
Subjects:
gastroretentive floating combination tablets
sustained release
amoxicillin
levofloxacin
<i>Helicobacter pylori</i>
effervescent tablets
Online Access:https://www.mdpi.com/1999-4923/16/10/1242

Internet

https://www.mdpi.com/1999-4923/16/10/1242

Similar Items